Experimental diabetes drug trial halted early – what happened?
Disease control
Terminated
This study tested a new drug called CK-0045 in 90 adults with type 2 diabetes and overweight or obesity. Participants received weekly injections of CK-0045 or a placebo for 16 weeks to see if it improved blood sugar after meals and reduced body weight. The trial was terminated ea…
Phase: PHASE2 • Sponsor: Cytoki Pharma • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC